The House Appropriations Committee allocated $2.2 billion for the Food and Drug Administration for fiscal 2012, or about 11.5% less than its current funding. The panel's late Tuesday vote also set expected user fees at $1.5 billion, which would bring the agency's total budget to $3.7 billion.
House panel marks $2.2 billion for FDA; fees set at $1.5 billion
The combined total of appropriations and user fees is nearly $9 million more than the agency's fiscal 2011 budget but about $560 million less than requested by President Barack Obama. The fees on applicants included about $856 million for prescription drugs and $67 million for medical devices.
The funding measure also would direct the FDA to drop its
involvement with the Interagency Working Group on Food Marketed to Children (PDF), which the previous Democrat-controlled Congress established to coordinate a federal review of obesity in children. The committee noted that the agency's “other critical existing responsibilities” needed to take precedence.
The committee also adopted an amendment by Rep. Denny Rehberg (R-Mont.) to require FDA rule-making decisions based on “hard science” and to determine that regulations are justified by expected benefits.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.